Portfolio

	InflammaGen was formed to treat shock and multi organ failure which lead to over 200,000 fatalities in the United States and an even greater number worldwide. In addition, there is mounting evidence which suggests that inflammation is the underlying cause of degenerative diseases including Alzheimer's, coronary artery disease, diabetes and even some cancers. InflammaGen is committed to testing and commercializing technologies to reduce inflammation in order to ameliorate disease and preserve human life.
	Consumers and business personnel share the common need of having to continuously monitor the environment for social, commercial and editorial information in order to take immediate and timely actions. Orbis Messaging's patent pending remote alert system provides a method by which end users are able to take immediate actions on hand held devices based on pre-determined triggers (such as when stocks reach 52 weeks highs or lows, when prices are reached on auctions such as ebay, etc.). An example is a stock alert and trading system. The user would create a stock alert trigger on an Orbis server and would be notified immediately when the trigger condition (such as a stock reaching a target price) is met. The user can receive the alert on any portable device including a cell phone and can initiate trading actions on the same device such as a cell phone. This ability to act in real time allows individuals to operate efficiently without having to be in an office, at home in front of a computer or at a WIFI hot spot location.
	Blitzfile is a P2P system involving both a business process and technology that combines certain aspects of swarming technology with a UDP based firewall penetration system. It also uses nested encryption with both public and private keys to secure content.
	The official Inhibex website will soon be online. Please check back soon...
	HamiltonTech Capital invests in growth and expansion-stage 'technology-enabled' private companies. The firm focuses such investments in the high-tech (including IT applications and infrastructure) and med-tech (including therapeutic medical devices, services, drug delivery systems and technologies for drug development) industries.